08. January 2020, Koblenz / Piacenza (Italy)
CompuGroup Medical SE acquires Italian company H&S Qualità nel Software SpAKoblenz / Piacenza (Italy), January 08, 2020 – CompuGroup Medical SE (CGM), a leading eHealth company worldwide, concluded a transaction to acquire 100% of H&S Qualità nel Software SpA on January 02, 2020. With the acquisition of the provider of telemedicine solutions and ICT services for domiciliary care providers, CGM is expanding its portfolio to include powerful solutions for health and social-care providers.
27. December 2019, Koblenz
CompuGroup Medical acquires EPSILOG SASKoblenz, December 27 2019 – CompuGroup Medical SE (CGM) is acquiring 100 % of EPSILOG SAS (EPSILOG), based in Castries, France. Today, CompuGroup Medical SE, as purchaser, and Hevanance S.à r.l. and Goodwill Systems S.à r.l., as sellers, have signed an agreement regarding the sale and purchase of 100 % of the shares in MB Invest SAS which is the sole owner of EPSILOG SAS. EPSILOG's key product is VEGA, an ambulatory information system with a leading position in French healthcare IT for psychotherapists and nurses. CompuGroup Medical is thereby strengthening its position in France, complementing its portfolio to address new customer groups in France. The agreed purchase price for EPSILOG amounts to EUR 72 million and is subject to further adjustments post-closing. In 2018, EPSILOG SAS had revenues of more than EUR 14 million and an EBITDA of approximately EUR 5 million with 44.000 customers.
15. November 2019, Koblenz
First eHealth connector receives approval for use in telematics infrastructureCompuGroup Medical Deutschland AG (CGM) is the first manufacturer to receive gematik's approval for the use of an eHealth connector, the KoCoBox MED, in telematics infrastructure (TI). For the first time in medical care, new eHealth applications, such as emergency data management (Notfalldatenmanagement, NFDM) and the electronic medication plan (Elektronischer Medikationsplan, eMP), can now be stored on the electronic health card (Elektronische Gesundheitskarte, eGK). With this approval, CGM once again confirms its responsibility as market leader and sets another important milestone in the digitization of the healthcare system.
07. November 2019, Koblenz
CompuGroup Medical grows in third quarter 2019 in all segments, guidance confirmedCompuGroup Medical SE, one of the leading providers of eHealth solutions, looks back on a successful third quarter of 2019.
15. October 2019, Koblenz
Dr. Eckart Pech joins Management Board of CompuGroup Medical SEDr. Eckart Pech will join the Management Board of CompuGroup Medical SE on November 1, 2019, and will lead the newly created Consumer and Health Management Information Systems segment. The Koblenz-based company, one of the world's largest providers of eHealth solutions, aims to further strengthen its role as a driving force for connectivity within the healthcare sector.
15. October 2019, Koblenz
Change in the Management Board of CompuGroup MedicalUwe Eibich, member of the Management Board of CompuGroup Medical SE and member of the Management Board of CGM Deutschland AG, will resign from office at his request with effect from 31 December 2019.
05. September 2019, Koblenz
CompuGroup Medical SE promoted to MDAXCompuGroup Medical SE shares will in future be listed in the MDAX, as Deutsche Börse announced. The change in the index composition will take effect on September 23. The company meets the two required quantitative admission criteria of market capitalization and trading volume.
08. August 2019, Koblenz
CompuGroup Medical SE reaffirms guidance for 2019CompuGroup Medical SE (CGM) has reported its financial results for the second quarter of 2019 today. Consolidated revenue was around EUR 187 million, just slightly below the exceptional quarter of the previous year, which was marked by the peak of the rollout of the telematics infrastructure (TI). Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) on a pro forma basis amounted to EUR 44 million in the second quarter of 2019, with an operating margin of 24%. The guidance for the full year 2019 with revenues in the amount of EUR 720 to 750 million and an EBITDA of EUR 190 to 205 million is reaffirmed.
06. August 2019, Koblenz
CGM strengthens Investor Relations: Claudia Thomé to join as new Head of Investor RelationsAs of September 1, 2019, Claudia Thomé, currently Co-Head of Investor Relations at Axel Springer SE, will take on the newly created position Head of Investor Relations at CompuGroup Medical SE and report to CFO Michael Rauch.
04. July 2019, Koblenz
More than every second measles infection occurs in adults – doctor's practices provide helpFewer measles cases and higher vaccination rates in adults thanks to better consultation in the doctor's office: Intelligent software automatically alerts family doctors to recommended measles vaccinations during the health check-up of adult patients between 18 and 49 years of age. The system also points out their importance: More than half of all measles cases in Germany occur in adults. This functionality is now available to every third family practice in Germany at no additional cost.
28. June 2019, Milan
Italy: Electronic veterinary prescription is comingThe WINGESFAR pharmacy management system, the software leader of CompuGroup Medical (CGM) on the Italian pharmacy market, now enables efficiency and simplicity in the administration of electronic veterinary prescriptions. An update makes it possible to process the electronic veterinary prescription in the same way as the electronic prescription of medicinal products for human use.
28. May 2019, Koblenz
CompuGroup Medical Receives a Major Order for its Hospital Information SystemThe Niederösterreichische Landeskliniken-Holding (Lower Austrian Regional Hospital Holding – NÖLKH) has chosen the CGM CLINICAL Hospital Information System from CompuGroup Medical (CGM) as the basis for a harmonized and centralized information system group-wide in medicine and care.
06. May 2019, Koblenz
CompuGroup Medical SE Reports Results for First Quarter of 2019CompuGroup Medical SE (CGM) today reported its financial results for the first quarter of 2019. The Koblenz-based company, one of the world's leading providers of eHealth solutions, generated a revenue of EUR 175 million compared to EUR 166 million in the same period of the previous year. Also favored by regulatory accounting changes, consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) and operating margin both rose to EUR 50 million and 28 percent in the first quarter of 2019, compared with EUR 39 million and 23 percent in the same period of the previous year.
15. April 2019, Koblenz
Upcoming changes to the CGM Management BoardCompuGroup Medical SE (CGM) today announced that Christian Teig will be departing from his position as Chief Financial Officer effective July 31st, 2019. CGM has appointed Michael Rauch who will take over as new CFO from August 1st, 2019. Christian Teig will remain for some time at CGM to ensure a smooth transition.
25. February 2019, Koblenz
CompuGroup Medical SE acquires Dutch company Qualizorg B.V.CompuGroup Medical SE (CGM), a leading eHealth company worldwide, concluded a transaction to acquire 100% of Qualizorg B.V. CompuGroup Medical expands its commitment in one of the most advanced European eHealth systems and markets.
04. February 2019, Koblenz
CompuGroup Medical SE – Preliminary Results 2018CompuGroup Medical SE (CGM), one of the world's leading providers of eHealth solutions, today announced the preliminary financial results for the fourth quarter and full fiscal year 2018. The Koblenz-based company closed the fourth quarter with revenues of EUR 194 million, representing organic growth of 18 percent compared with EUR 164 million in the same period of the previous year. With an operating margin of 26 percent, consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) rose from EUR 37 million (2017) to EUR 51 million in the fourth quarter of 2018.
08. November 2018, Koblenz
CompuGroup Medical SE announces results for third quarter of 2018CompuGroup Medical SE (CGM) today announced its financial report for the third quarter of 2018. With a turnover of EUR 166 million, the company could achieve organic growth of 20 percent compared to the same period last year (EUR 138 million). EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to EUR 37 million compared to EUR 28 million in the third quarter of 2017, with the operating margin rising from 20 to 22 percent.
02. October 2018, Koblenz
CompuGroup Medical strengthens its leadershipThe Supervisory Board of CompuGroup Medical SE (CGM) has today created two Executive Board positions for the outpatient and inpatient healthcare sectors. Dr. Ralph Körfgen (board member for the out-patient sector) and Hannes Reichl (board member for the inpatient sector) were appointed as additional members of the Executive Board.
07. September 2018, Koblenz
CompuGroup Medical SE both in TecDAX and SDAX nowThe restructuring on the German Stock Exchange confirms CompuGroup Medical's (CGM) listing in the TecDAX. In addition, CGM will be included in the SDAX.
13. August 2018, Koblenz